You are here: All Products  > Impact Therapeutics Granted CFDA Approval for China Test of PARP Inhibitor

Impact Therapeutics Granted CFDA Approval for China Test of PARP Inhibitor

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products